-
Why ChromaDex Shares Spiked 111% Today
Thursday, February 25, 2021 - 10:57pm | 255Chromadex Corp (NASDAQ: CDXC) shares jumped 111% in the regular and after-hours sessions today. What Happened: The price movement on Thursday was accompanied by intense trading with volumes of 116.67 million. The average volume for ChromaDex shares is 523,511. While there were no immediate triggers...
-
China's Sinopharm COVID-19 Vaccine Shows 79.34% Efficacy
Wednesday, December 30, 2020 - 2:27am | 396China's Sinopharm Group (OTC: SHTDY) said Wednesday its COVID-19 vaccine candidate BBIBP-CorV — developed in partnership with Beijing Biological Products Institute Co. Ltd — shows 79.34% efficacy, Reuters reports. What Happened: Beijing Biological...
-
AstraZeneca COVID-19 Vaccine Shows Up To 90% Efficacy In Advanced Trials
Monday, November 23, 2020 - 4:11am | 494AstraZeneca Plc (NYSE: AZN) and Oxford University’s COVID-19 vaccine prevented 70% of the inoculated trial participants from developing COVID-19, early analysis of trial data indicates. What Happened: The results were based on data gathered from two different dosing regimens. One dosing...
-
Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine
Monday, November 16, 2020 - 3:31am | 460Johnson & Johnson (NYSE: JNJ) has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday. What Happened: Johnson & Johnson aims to administer its experimental COVID-19 vaccine to 30,000...
-
Sinovac COVID-19 Vaccine Trial Halted In Brazil Over Adverse Event
Tuesday, November 10, 2020 - 4:31am | 451Brazilian health regulator has decided to halt clinical trials of a frontrunning Chinese vaccine following a “severe adverse event” observed in a participant, Bloomberg reported Monday. CoronaVac, a vaccine candidate developed through joint efforts by Chinese biopharma...
-
GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug
Tuesday, November 3, 2020 - 1:00pm | 402Biopharmaceutical company GW Pharmaceuticals plc (NASDAQ: GWPH) revealed Tuesday that its revenue for the third quarter hit $137.1 million, up by 51% year-over-year. For the first nine months of this fiscal year, total revenue amounted to $378.6 million versus $202.3 million for the...
-
AstraZeneca Could Resume US COVID-19 Vaccine Trial This Week As FDA Review Complete: Report
Wednesday, October 21, 2020 - 12:35am | 348The U.S. Food and Drug Administration (FDA) has completed a review of adverse events observed in participants of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine clinical trial, according to Reuters. What Happened: The U.S. trial of the British company's vaccine candidate...
-
Johnson & Johnson COVID-19 Vaccine Trial Paused Over Participant Developing Unexplained Illness
Monday, October 12, 2020 - 9:52pm | 479Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccine trial has been paused over a participant developing an unexplained illness, Stat reported late Monday. The company later confirmed the move in a statement. What Happened: The pharmaceutical company reportedly told the researchers conducting...
-
Regeneron CEO Says More Testing Needed For Antibody Cocktail After Trump Touted It As COVID-19 'Cure'
Sunday, October 11, 2020 - 11:42pm | 419Regeneron Pharmaceuticals Inc (NASDAQ: REGN) CEO Leonard Schleifer in a televised interview suggested that more clinical testing was needed to measure the company's antibody cocktail's effectiveness against COVID-19, in contrast to President Donald Trump who earlier claimed...
-
Novavax Shares Surge 7% As It Begins Late-Stage COVID-19 Vaccine Trials
Thursday, September 24, 2020 - 10:23pm | 394Novavax, Inc (NASDAQ: NVAX) said Thursday it was launching a large-scale diverse Phase 3 study of its COVID-19 vaccine in the United Kingdom — causing a more than 7% spike in the company’s shares after the closing bell. What Happened: The study will enroll up to 100,000 individuals...
-
Sinovac Plans To Expand COVID-19 Vaccine Trials To Children And Adolescents
Thursday, September 17, 2020 - 3:15am | 446Sinovac Biotech has plans to expand the clinical trial of its COVID-19 vaccine trial to children and adolescents later this month. What Happened: The Chinese vaccine maker hopes to carry out the study on 552 healthy participants ranging between the ages of three and 17, according to information the...
-
AstraZeneca Gets India Go-Ahead To Resume COVID-19 Vaccine Trials, US Nod Awaited
Wednesday, September 16, 2020 - 1:45pm | 332AstraZeneca plc (NYSE: AZN) COVID-19 vaccine clinical trial is set to resume in India after local partner Serum Institute of India received the go-ahead from Indian regulators, Reuters reported Wednesday. What Happened: The Drugs Controller General of India has approved the trial of the...
-
Pfizer Says COVID-19 Vaccine Only Showed Moderate Side-Effects In Initial Late-Stage Trials
Wednesday, September 16, 2020 - 3:05am | 398Pfizer Inc (NYSE: PFE) on Tuesday said only mild-to-moderate side effects were observed in volunteers administered with its COVID-19 vaccine in late-stage human trials. What Happened: The ongoing Phase 3 trials were carried out in such a way that 50% of the participants received its...
-
Pfizer Seeks FDA Nod To Expand Late-Stage COVID-19 Vaccine Trial
Sunday, September 13, 2020 - 10:21pm | 420Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Saturday they are seeking the United States Food and Drug Administration approval to expand the late-stage clinical trial of their COVID-19 vaccine, by significantly upping the number of participants and increasing their...
-
AstraZeneca COVID-19 Vaccine Trial Halt A 'Wake-Up Call,' WHO Says
Thursday, September 10, 2020 - 9:54pm | 444AstraZeneca Plc’s (NYSE: AZN) COVID-19 vaccine trial halt is an indicator that vaccine development is “not always a fast and a straight road,” according to the World Health Organization Chief Scientist Dr. Soumya Swaminathan. What Happened: The WHO official said that the vaccine...